Intraepidermal nerve fibre density in cancer patients receiving adjuvant chemotherapy

Anticancer Research

Volumn 31, Issue 12, 2011, Pages 4413-4416

  Koskinen, Mika J ^a   Kautio, Anna Liisa ^a   Haanpää, Maija L ^b,c   Haapasalo, Hannu K ^a   Kellokumpu Lehtinen, Pirkko L ^a   Saarto, Tiina ^b   Hietaharju, Aki J ^a  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c ORTON   (Finland)

Author keywords

Adjuvant chemotherapy; Cancer; Docetaxel; Intraepidermal nerve fibres; Neuropathy; Neurotoxicity; Oxaliplatin; Skin biopsies

Indexed keywords

DOCETAXEL; OXALIPLATIN;

ADJUVANT THERAPY; ADULT; AGED; ALLODYNIA; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER PATIENT; CELL DENSITY; CLINICAL ARTICLE; COLD ALLODYNIA; COLORECTAL CANCER; CONTROLLED STUDY; COORDINATION DISORDER; DYSESTHESIA; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; HYPERALGESIA; HYPESTHESIA; INTRAEPIDERMAL NERVE FIBER DENSITY; MALE; MICROSCOPY; MORPHOMETRICS; MULTIPLE CYCLE TREATMENT; NERVE FIBER; NEUROPATHY; NEUROTOXICITY; PARESTHESIA; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; SKIN BIOPSY; SYMPTOM;

ADULT; AGED; ANTINEOPLASTIC AGENTS; BIOPSY; CHEMOTHERAPY, ADJUVANT; EPIDERMIS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; NERVE FIBERS; ORGANOPLATINUM COMPOUNDS; PILOT PROJECTS; PROSPECTIVE STUDIES; SKIN; TAXOIDS;

EID: 84855163835     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Cata CP, Weng H-R, Lee BN, Reuben JM and Dougherty PM: Clinical and experimental findings in humans and animals with chemotherapy-induced peripheral neuropathy. Minerva Anestesiol 72: 151-169, 2006.
2. Ocean AJ and Vahdat LT: Chemotherapy-induced peripheral neuropathy: pathogenesis and emerging therapies. Support Care Cancer 12: 619-625, 2004. (Pubitemid 39280311)
3. Cavaletti G and Marmiroli P: Chemotherapy-induced peripheral neurotoxicity. Nat Rev Neurol 6: 657-666, 2010.
4. Lee JJ and Swain SM: Peripheral neuropathy induced by microtubule-stabilizing agents. J Clin Oncol 24: 1633-1642, 2006. (Pubitemid 46638788)
5. Attal N, Bouhassira D, Gautron M, Vaillant JN, Mitry E, Lepère C, Rougier P and Guirimand F: Thermal hyperalgesia as a marker of oxaliplatin neurotoxicity: a prospective quantified sensory assessment study. Pain 144: 245-252, 2009.
6. Sommer C and Lauria G: Skin biopsy in the management of peripheral neuropathy. Lancet Neurol 6: 632-642, 2007. (Pubitemid 46921057)
7. Lauria G, Hsieh ST, Johansson O, Kennedy WR, Leger JM, Mellgren SI, Nolano M, Merkies IS, Polydefkis M, Smith AG, Sommer C and Valls-Solé J: European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. J Periph Nerv Syst 15: 79-92, 2010.
8. Koskinen M, Hietaharju A, Kyläniemi M, Peltola J, Rantala I, Udd B and Haapasalo H: A quantitative method for the assessment of intraepidermal nerve fibers in small-fiber neuropathy. J Neurol 252: 789-794, 2005. (Pubitemid 40984853)
9. Lipton RB, Galer BS, Dutcher JP, Portenoy RK, Pahmer V, Meller F, Arezzo JC and Wiernik PH: Large and small fibre type sensory dysfunction in patients with cancer. J Neurol Neurosurg Psychiatry 54: 706-709, 1991.
10. Burakgazi AZ, Messersmith W, Vaidya D, Hauer P, Hoke A and Polydefkis M: Longitudinal assessment of oxaliplatin-induced neuropathy. Neurology 77: 980-986, 2011.